SEARCH

SEARCH BY CITATION

References

  • 1
    Friedman MA, Carter SK The therapy of osteogenic sarcoma. Current status and thoughts for the future. J Surg Oncol 1972; 4: 482510.
  • 2
    Jaffe N, Frei E, Watts H et al. High-dose methotrexate in osteogenic sarcoma. A 5-year experience. Cancer Treat Rep 1978: 62 259264.
  • 3
    Pratt CB, Howarth C, Ransom JL et al. High-dose methotrexate alone and in combination therapy for measurable primary or metastatic osteosarcoma. Cancer Treat Rep 1980; 64: 1120.
  • 4
    Rosen G, Nirenberg A, Caparros B Evaluation of high dose methotrexate (HDMTX) with citrovorum factor rescue (CFR) single agent chemotherapy in osteogenic sarcoma (OSA). Proc Am Assoc Cancer Res 1980; 21: 177.
  • 5
    Rosen G, Nirenberg A, Juergens H, Caparros B, Huvos AG Response of primary osteogenic sarcoma to single agent therapy wth high-dose methotrexate with citrovorum factor rescue. In NelsonJD, GrassiC (eds.): Current Chemotherapy and Infectious Disease. Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Vol 2. Washington DC: The American Society for Microbiology, 1980: 16331635.
  • 6
    Cortes EP, Holland JF, Wang JJ, Glidewell O Adriamycin (NSC-123127) in 87 patients with osteogenic sarcoma. Cancer Chemother Rep (Part 3) 1975; 6: 305313.
  • 7
    Pratt CB, Shanks EC Doxorubicin in treatment of malignant solid tumors in children. Am J Dis Child 1974; 127: 534536.
  • 8
    Tan C, Rosen G, Ghavimi F et al. Adriamycin (NSC-123127) in pediatric malignancies. Cancer Chemother Res 1975; 6: 259266.
  • 9
    Wang JJ, Holland JF, Sinks LF Phase II study of adriamycin (NSC-123127) in childhood solid tumors. Cancer Chemother Rep 1975; 6: 267270.
  • 10
    Finklestein JZ, Hittle RE, Hammond GD Evaluation of a high dose cyclophosphamide regimen on childhood tumors. Cancer 1969; 23: 12391242.
  • 11
    Mosende C, Guttierez M, Caparros B, Rosen G Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer 1977; 40: 27792786.
  • 12
    Gaymon P, Baum E, Greenberg L et al. A phase II trial of cis-platinum diammine dichloride (DDP) (NSC-119825) in refractory childhood tumors. A CCSG trial. Proc Am Assoc Cancer Res 1979; 20: 394.
  • 13
    Ochs JJ, Freeman AI, Douglass HO et al. Cis-dichlorodiammine-platinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 1978; 62: 239245.
  • 14
    Pratt CB, Hayes FA, Green AA et al. Phase II pharmaco-kinetic study of cisplatinum diamminedichloride (CDDP) in children with solid tumors. Proc Am Assoc Cancer Res 1979; 20: 361.
  • 15
    Rosen G, Nirenberg A, Caparros B et al. Cis-platinum in metastatic osteogenic sarcoma. In PrestaykoAW, CrookeST, CarterSK (eds.) Cisplatin: Current Status and New Developments. New York: Academic Press, 1980: 465475.
  • 16
    Cortes EP, Necheles TF, Holland JF, Glidewell O Adriamycin (ADR) alone versus ADR and high dose methotrexate-citrovorum factor rescue (HDM-CFR) as adjuvant to operable primary osteosarcoma. A randomized study by Cancer and Leukemic Group B (CALGB). Proc Am Assoc Cancer Res 1979; 20: 412.
  • 17
    Ettinger LJ, Douglass HO, Higby DJ et al. Adjuvant adriamycin (Adr) and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer 1981; 47: 248254.
  • 18
    Pratt CB, Shanks EC, Hustu HO et al. Adjuvant multiple drug chemotherapy for osteogenic sarcoma of the extremity. Cancer 1977; 39: 5157.
  • 19
    Rosen G, Marcove RC, Caparros B et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979; 43: 21632177.
  • 20
    Rosen G, Murphy ML, Huvos AG et al. Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 1976; 37: 111.
  • 21
    Rosenberg SA, Chabner BA, Young RC et al. Treatment of osteogenic sarcoma. Effect adjuvant high-dose methotrexate after amputation. Cancer Treat Rep 1979; 63: 739751.
  • 22
    Sutow WW, Gehan EA, Dyment PA et al. Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg (Am) 1979; 61A: 207215.
  • 23
    Sutow WW, Sullivan MP, Wilbur JR Cangir A A study of adjuvant chemotherapy in osteogenic sarcoma. J Clin Phamacol 1975; 7: 530533.
  • 24
    Marcove RC, Mike V, Hajek JV et al. Osteogenic sarcoma under the age of 21. A review of 145 preoperative cases. J Bone Joint Surg (Am) 1970; 52: 411423.
  • 25
    Rosen G, Huvos AG, Mosende C et al. Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 1978; 41: 841849.
  • 26
    Marcove RC En bloc resection for osteogenic sarcoma. Can J Surg 1977; 20: 521528.
  • 27
    Huvos AG, Rosen G, Marcove RC Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 1977; 101: 1418.
  • 28
    Frei E Clincial cancer research: an embattled species. 12th Annual David A. Karnofsky Memorial Lecture at 1981 meeting of American Association for Cancer research. Cancer (in press).
  • 29
    Van Ness CP Rotationplasty in the treatment of congenital defects of the femur. J Bone Joint Surg (Br) 1950; 32B: 12.
  • 30
    Marcove RC, Lewis MM, Huvos AG En bloc, upper humeral interscapulo-thoracic resection. The Tikhoff-Linberg procedure. Clin Orthop 1977; 124: 219228.
  • 31
    Mehta BM, Juergens H Allen JC, Rosen G, Hutchison DJ Distribution of methotrexate, citrovorum factor, and 5-methyltetrahydrofolate after high-dose methotrexate-leucovorin rescue in osteogenic sarcoma. In NelsonJD, GrassiC (ed.): Current Chemotherapy and Infectious Disease. Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, vol. 2. Washington DC: The American Society for Microbiology, 1980: 16351636.
  • 32
    Nirenberg A, Mosende C, Mehta BM, Gisolfi AL, Rosen G High dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treat Rep 1977; 61: 779783.
  • 33
    Allen JC, Rosen G, Mehta B, Horten B Leukoencephalopathy following high dose I. V. methotrexate chemotherpay with leucovorin rescue. Cancer Treat Rep 1980; 64: 12611273.
  • 34
    Nirenberg A, Cacavio A, Bru G, Caparros B, Rosen G Ambulatory high dose cisplatinum (HD-DDP) with mannitol diuresis: a treatment system without renal, auditory or biochemical toxicity. Proc Am Soc Clin Oncol 1981; 22: 528.
  • 35
    Sims FH, Unni KK, Beabout JW et al. Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg (Am) 1979; 61A: 207215.
  • 36
    Burchenal J From wild fowl to stalking horses: Alchemy in chemotherapy. Cancer 1975; 35: 11211135.